201 related articles for article (PubMed ID: 15047217)
1. Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines.
Apte SM; Bucana CD; Killion JJ; Gershenson DM; Fidler IJ
Gynecol Oncol; 2004 Apr; 93(1):78-86. PubMed ID: 15047217
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
Hwang RF; Yokoi K; Bucana CD; Tsan R; Killion JJ; Evans DB; Fidler IJ
Clin Cancer Res; 2003 Dec; 9(17):6534-44. PubMed ID: 14695158
[TBL] [Abstract][Full Text] [Related]
3. Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential.
Kitadai Y; Sasaki T; Kuwai T; Nakamura T; Bucana CD; Hamilton SR; Fidler IJ
Int J Cancer; 2006 Dec; 119(11):2567-74. PubMed ID: 16988946
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
Lev DC; Kim SJ; Onn A; Stone V; Nam DH; Yazici S; Fidler IJ; Price JE
Clin Cancer Res; 2005 Jan; 11(1):306-14. PubMed ID: 15671560
[TBL] [Abstract][Full Text] [Related]
5. Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma.
Apte SM; Fan D; Killion JJ; Fidler IJ
Clin Cancer Res; 2004 Feb; 10(3):897-908. PubMed ID: 14871965
[TBL] [Abstract][Full Text] [Related]
6. Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor β is associated with lymphatic metastasis in human gastric carcinoma.
Kodama M; Kitadai Y; Sumida T; Ohnishi M; Ohara E; Tanaka M; Shinagawa K; Tanaka S; Yasui W; Chayama K
Cancer Sci; 2010 Sep; 101(9):1984-9. PubMed ID: 20624165
[TBL] [Abstract][Full Text] [Related]
7. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.
Dabrow MB; Francesco MR; McBrearty FX; Caradonna S
Gynecol Oncol; 1998 Oct; 71(1):29-37. PubMed ID: 9784315
[TBL] [Abstract][Full Text] [Related]
8. Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer.
Matei D; Emerson RE; Lai YC; Baldridge LA; Rao J; Yiannoutsos C; Donner DD
Oncogene; 2006 Mar; 25(14):2060-9. PubMed ID: 16331269
[TBL] [Abstract][Full Text] [Related]
9. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T
Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of platelet-derived growth factor and its receptors in soft tissue malignant fibrous histiocytoma.
Yamamoto T; Akisue T; Marui T; Fujita I; Matsumoto K; Kawamoto T; Hitora T; Nakatani T; Nagira K; Kurosaka M
Anticancer Res; 2003; 23(5b):4325-8. PubMed ID: 14666646
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
[TBL] [Abstract][Full Text] [Related]
12. PDGF BB induces VEGF secretion in ovarian cancer.
Matei D; Kelich S; Cao L; Menning N; Emerson RE; Rao J; Jeng MH; Sledge GW
Cancer Biol Ther; 2007 Dec; 6(12):1951-9. PubMed ID: 18075302
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of imatinib and carboplatin on VEGF, PDGF and PDGF-Rα/ß expression in squamous cell carcinoma of the head and neck in vitro.
Schultz JD; Rotunno S; Riedel F; Anders C; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Int J Oncol; 2011 Apr; 38(4):1001-12. PubMed ID: 21249316
[TBL] [Abstract][Full Text] [Related]
15. Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells.
Malavaki CJ; Roussidis AE; Gialeli C; Kletsas D; Tsegenidis T; Theocharis AD; Tzanakakis GN; Karamanos NK
FEBS J; 2013 May; 280(10):2477-89. PubMed ID: 23374223
[TBL] [Abstract][Full Text] [Related]
16. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
Uren A; Merchant MS; Sun CJ; Vitolo MI; Sun Y; Tsokos M; Illei PB; Ladanyi M; Passaniti A; Mackall C; Toretsky JA
Oncogene; 2003 Apr; 22(15):2334-42. PubMed ID: 12700668
[TBL] [Abstract][Full Text] [Related]
17. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.
Xu L; Tong R; Cochran DM; Jain RK
Cancer Res; 2005 Jul; 65(13):5711-9. PubMed ID: 15994946
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
19. Platelet derived growth factor (PDGF) responsive epidermis formed from human keratinocytes transduced with the PDGF beta receptor gene.
Rollman O; Jensen UB; Ostman A; Bolund L; Gústafsdóttir SM; Jensen TG
J Invest Dermatol; 2003 May; 120(5):742-9. PubMed ID: 12713575
[TBL] [Abstract][Full Text] [Related]
20. The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically.
Garofalo A; Naumova E; Manenti L; Ghilardi C; Ghisleni G; Caniatti M; Colombo T; Cherrington JM; Scanziani E; Nicoletti MI; Giavazzi R
Clin Cancer Res; 2003 Aug; 9(9):3476-85. PubMed ID: 12960140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]